DGAP-Adhoc: Dermapharm Holding SE: Acquisition of Allergopharma

2020. február 19., szerda, 15:57





DGAP-Ad-hoc: Dermapharm Holding SE / Key word(s): Takeover


Dermapharm Holding SE: Acquisition of Allergopharma


19-Feb-2020 / 15:57 CET/CEST


Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.


The issuer is solely responsible for the content of this announcement.




Disclosure of insider information pursuant to Section 17 (1) 1 of Regulation (EU)

No. 596/2014 on market abuse, as amended (Market Abuse Regulation - MAR)



Dermapharm Holding SE: Acquisition of Allergopharma



Grünwald, February 19, 2020 - Dermapharm Holding SE (WKN: A2GS5D, ISIN: DE000A2GS5D8) signed a contract via Dermapharm Beteiligungs GmbH to acquire Allergopharma GmbH & Co. KG, based in Reinbek near Hamburg, Germany, a subsidiary of Merck KGaA, Darmstadt, Germany. With the closing of the transaction, Dermapharm Beteiligungs GmbH will acquire 100.00 percent of the shares in the company that specializes in desensitization of allergies. The parties have agreed not to disclose the purchase price.



The purchase agreement is still subject to the approval of the relevant supervisory authority. The Management Board expects the transaction to be completed by the end of the second quarter of 2020.



>End of the Ad hoc announcement<



 



Contacts



 





Investor Relations &

Corporate Communications

Britta Hamberger

Phone: +49 (0)89 - 64186-233

Fax: +49 (0)89 - 64186-165

email: ir@dermapharm.com
cometis AG

Claudius Krause

Phone: +49 (0)611 - 205855-28

Fax: +49 (0)611 - 205855-66

email: ir@dermapharm.com

 

 



 











19-Feb-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

























Language: English
Company: Dermapharm Holding SE

Lil-Dagover-Ring 7

82031 Grünwald

Germany
Phone: +49 (0)89 64 86-0
E-mail: ir@dermapharm.com
Internet: ir.dermapharm.de
ISIN: DE000A2GS5D8
WKN: A2GS5D
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Stuttgart, Tradegate Exchange
EQS News ID: 979211





 
End of Announcement DGAP News Service




979211  19-Feb-2020 CET/CEST







fncls.ssp?fn=show_t_gif&application_id=979211&application_name=news&site_id=geo_holding_tug
Tilos a hír bármilyen adatbázisba történő mentése vagy annak továbbítása harmadik fél számára;kereskedelmi viszonylatban vagy kereskedelmi céllal csak a Deutsche Gesellschaft für Ad-hoc-Publizität mbh írásos engedélyével történhet.